+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments), Type (IVD, LDT), Application (Breast Cancer, Lung Cancer), End-use, Test Type, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 240 Pages
  • November 2023
  • Region: Global
  • Grand View Research
  • ID: 4753467
Description Jump to:
The global cancer diagnostics market size is expected to reach USD 162.31 billion by 2030, according to the report. The market is expected to expand at a CAGR of 6.16% from 2024 to 2030. Increasing number of programs to raise awareness about cancer by several organizations is a major factor accountable for increased demand for diagnostic products worldwide. Partnerships and collaborations undertaken by the National Cervical Cancer Coalition, WHO, CDC, the U.S. Preventive Services Task Force, & others for increasing cervical cancer screening are among the major factors expected to boost market growth during the forecast period.

Several countries have thus undertaken measures to increase screening for early diagnosis and help existing patients. For instance, Ayushman Bharat and the Prime Minister’s National Relief Fund was initiated by the Indian government for patients who require assistance during the treatment. Similarly, the Indian government’s Department of Biotechnology signed a contract with Cancer Research UK to conduct research for affordable approaches to diagnosis and treatment.

Liquid biopsy solutions are being increasingly adopted as MCED tests as they are easily accessible for clinical applications. In recent years, they have gained regulatory approval with comprehensive and multi-cancer diagnostic approaches. Breakthrough advancements in the field and ongoing studies for early detection are contributing to market growth. Moreover, technologies such as circulating tumor DNA, extracellular vesicles, and circulating tumor cells are paving the way for better cancer care. Versatile technologies can provide integrated solutions for maximizing the potential of liquid biopsy.

Advantage of using companion diagnostics is the overall reduction in time and costs incurred by pharmaceutical and diagnostic companies. The time required to develop and commercialize a novel molecule generally consists of 10 to 15 years. Co-development of diagnostics and drugs facilitates accelerated regulatory approval processes, which significantly reduces costs. . Since the FDA guidance draft for the development of an IVD companion diagnostic device with a therapeutic product was published in 2016, many manufacturers encourage the development of companion diagnostic assays in the field of oncology. This is anticipated to positively impact market growth during the forecast period.

Cancer Diagnostics Market Report Highlights

  • Based on product, the consumables segment held the largest share of 59.98% in 2023 and is anticipated to grow at the fastest growth rate over the forecast period
  • Based on type, in vitro diagnostics (IVD) segment dominated the in 2023 with a share of 52.75% due to the increasing adoption of IVD owing to the rise in testing amid COVID-19 pandemic.
  • The breast cancer application segment is expected to grow lucratively over the forecast period due to growth in initiatives to spread awareness across the population and increase in R&D activities.
  • Based on end-use, the laboratories segment dominated the market due to efficient outpatient services. The hospitals segment is forecasted grow at a significant rate over the coming years attributed to an increase in the admittance of patients in hospitals
  • The biopsy segment is anticipated to grow at a significant growth rate due to various benefits associated with the test, including early detection of the disease
  • North America dominated the global cancer diagnostics market in 2023, owing to rise in the number of approvals of new diagnostic tests
  • The Asia Pacific is expected to grow considerably in the future owing to due to the rising prevalence and the presence of key players

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.1.1. Market Definitions
1.2. Objectives
1.2.1. Objective - 1
1.2.2. Objective - 2
1.2.3. Objective - 3
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Product and Type Snapshot
2.3. Application and End-use Snapshot
2.4. Test Type Snapshot
2.5. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers
3.4.1. Rising Prevalence of Cancer
3.4.2. Technological Advancements
3.4.3. Rising Initiatives Undertaken by Public and Private Organizations
3.4.4. Extensive R&D for the Development of Novel Testing Solutions
3.5. Market Restraint Analysis
3.5.1. High Cost of Diagnostic Imaging
3.5.2. Radiation Exposure Likely to Limit Usage of CT Scans
3.5.3. Rising Adoption of Refurbished Diagnostic Imaging Systems
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.6.2. Porter’s Five Forces Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Cancer Diagnostics Market: Product Movement Analysis
4.2. Instruments
4.2.1. Instruments Market, 2018 - 2030 (USD Billion)
4.2.2. Pathology Based-Instruments
4.2.2.1. Slide Staining Systems
4.2.2.1.1. Slide Staining Systems Market, 2018 - 2030 (USD Billion)
4.2.2.2. Tissue Processing Systems
4.2.2.2.1. Tissue Processing Systems Market, 2018 - 2030 (USD Billion)
4.2.2.3. Cell Processors
4.2.2.3.1. Cell Processors Systems Market, 2018 - 2030 (USD Billion)
4.2.2.4. PCR Instruments
4.2.2.4.1. PCR Instruments Market, 2018 - 2030 (USD Billion)
4.2.2.5. NGS Instruments
4.2.2.5.1. NGS Instruments Market, 2018 - 2030 (USD Billion)
4.2.2.6. Microarrays
4.2.2.6.1. Microarrays Market, 2018 - 2030 (USD Billion)
4.2.2.7. Other Pathology-based Instruments
4.2.2.7.1. Other Pathology-based Instruments Market, 2018 - 2030 (USD Billion)
4.2.3. Imaging Instruments
4.2.4. Others
4.3. Consumables
4.3.1. Consumables Market, 2018 - 2030 (USD Billion)
4.4. Services
4.4.1. Services Market, 2018 - 2030 (USD Billion)
Chapter 5. Type Business Analysis
5.1. Cancer Diagnostics Market: Type Movement Analysis
5.2. IVD
5.2.1. IVD Market, 2018 - 2030 (USD Billion)
5.2.2. IVD Market, By Type 2018 - 2030 (USD Billion)
5.2.2.1. Diagnosis
5.2.2.1.1. Diagnosis Market, 2018 - 2030 (USD Billion)
5.2.2.2. Early Detection
5.2.2.2.1. Early Detection Market, 2018 - 2030 (USD Billion)
5.2.2.3. Therapy Selection
5.2.2.3.1. Therapy Selection Market, 2018 - 2030 (USD Billion)
5.2.2.4. Monitoring
5.2.2.4.1. Monitoring Market, 2018 - 2030 (USD Billion)
5.2.3. IVD Market, By Technology 2018 - 2030 (USD Billion)
5.2.3.1. Polymerase Chain Reaction (PCR)
5.2.3.1.1. Polymerase Chain Reaction (PCR) Market, 2018 - 2030 (USD Billion)
5.2.3.2. In Situ Hybridization (ISH)
5.2.3.2.1. In Situ Hybridization (ISH) Market, 2018 - 2030 (USD Billion)
5.2.3.3. Immunohistochemistry (IHC)
5.2.3.3.1. Immunohistochemistry (IHC) Market, 2018 - 2030 (USD Billion)
5.2.3.4. Next-generation Sequencing (NGS)
5.2.3.4.1. Next-generation Sequencing (NGS) Market, 2018 - 2030 (USD Billion)
5.2.3.5. Microarrays
5.2.3.5.1. Microarrays Market, 2018 - 2030 (USD Billion)
5.2.3.6. Flow Cytometry
5.2.3.6.1. Flow Cytometry Market, 2018 - 2030 (USD Billion)
5.2.3.7. Immunoassays
5.2.3.7.1. Immunoassays Market, 2018 - 2030 (USD Billion)
5.2.3.8. Other IVD Testing Technologies
5.2.3.8.1. Other IVD Testing Technologies Market, 2018 - 2030 (USD Billion)
5.3. LDT
5.3.1. LDT Market, 2018 - 2030 (USD Billion)
5.4. Imaging
5.4.1. Imaging Market, 2018 - 2030 (USD Billion)
5.4.2. Magnetic Resonance Imaging (MRI)
5.4.2.1. Magnetic Resonance Imaging (MRI) Market, 2018 - 2030 (USD Billion)
5.4.3. Computed Tomography (CT)
5.4.3.1. Computed Tomography (CT) Market, 2018 - 2030 (USD Billion)
5.4.4. Positron Emission Tomography (PET)
5.4.4.1. Positron Emission Tomography (PET) Market, 2018 - 2030 (USD Billion)
5.4.5. Mammography
5.4.5.1. Mammography Market, 2018 - 2030 (USD Billion)
5.4.6. Ultrasound
5.4.6.1. Ultrasound Market, 2018 - 2030 (USD Billion)
5.4.7. Others
5.4.7.1. Others Market, 2018 - 2030 (USD Billion)
Chapter 6. Application Business Analysis
6.1. Cancer Diagnostics Market: Application Movement Analysis
6.2. Breast Cancer
6.2.1. Breast Cancer Market, 2018 - 2030 (USD Billion)
6.3. Colorectal Cancer
6.3.1. Colorectal Cancer Market, 2018 - 2030 (USD Billion)
6.4. Cervical Cancer
6.4.1. Cervical Cancer Market, 2018 - 2030 (USD Billion)
6.5. Lung Cancer
6.5.1. Lung Cancer Market, 2018 - 2030 (USD Billion)
6.6. Prostate Cancer
6.6.1. Prostate Cancer Market, 2018 - 2030 (USD Billion)
6.7. Skin Cancer
6.7.1. Skin Cancer Market, 2018 - 2030 (USD Billion)
6.8. Blood Cancer
6.8.1. Blood Cancer Market, 2018 - 2030 (USD Billion)
6.9. Kidney Cancer
6.9.1. Kidney Cancer Market, 2018 - 2030 (USD Billion)
6.10. Liver Cancer
6.10.1. Liver Cancer Market, 2018 - 2030 (USD Billion)
6.11. Pancreatic Cancer
6.11.1. Pancreatic Cancer Market, 2018 - 2030 (USD Billion)
6.12. Ovarian Cancer
6.12.1. Ovarian Cancer Market, 2018 - 2030 (USD Billion)
6.13. Others
6.13.1. Others Market, 2018 - 2030 (USD Billion)
Chapter 7. End-Use Business Analysis
7.1. Cancer Diagnostics Market: End-Use Movement Analysis
7.2. Hospitals
7.2.1. Hospitals Market, 2018 - 2030 (USD Billion)
7.3. Laboratories
7.3.1. Laboratories Market, 2018 - 2030 (USD Billion)
7.4. Others
7.4.1. Others Cancer Diagnostics Market, 2018 - 2030 (USD Billion)
Chapter 8. Test Type Business Analysis
8.1. Cancer Diagnostics Market: Test Type Movement Analysis
8.2. Biopsy
8.2.1. Biopsy Market, 2018 - 2030 (USD Billion)
8.2.2. Fine-needle Aspiration
8.2.2.1. Fine-needle Aspiration Market, 2018 - 2030 (USD Billion)
8.2.3. Core Biopsy
8.2.3.1. Core Biopsy Market, 2018 - 2030 (USD Billion)
8.2.4. Surgical Biopsy
8.2.4.1. Surgical Biopsy Market, 2018 - 2030 (USD Billion)
8.2.5. Skin Biopsy /Punch Biopsy
8.2.5.1. Skin Biopsy /Punch Biopsy Market, 2018 - 2030 (USD Billion)
8.2.6. Others
8.2.6.1. Others Market, 2018 - 2030 (USD Billion)
8.3. Others
8.3.1. Others Cancer Diagnostics Market, 2018 - 2030 (USD Billion)
Chapter 9. Product Business Analysis
9.1. Cancer Diagnostics Market: Product Movement Analysis
9.2. Instruments
9.2.1. Instruments Market, 2018 - 2030 (USD Billion)
9.3. Consumables Kits and Reagents
9.3.1. Consumables Kits and Reagents Market, 2018 - 2030 (USD Billion)
9.4. Software and Services
9.4.1. Software and Services Market, 2018 - 2030 (USD Billion)
Chapter 10. Regional Business Analysis
10.1. Cancer Diagnostics Market Share By Region, 2023 & 2030
10.2. North America
10.2.1. North America Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.2.2. U.S.
10.2.2.1. Key Country Dynamics
10.2.2.2. Target Disease Prevalence
10.2.2.3. Competitive Scenario
10.2.2.4. Regulatory Framework
10.2.2.5. Reimbursement Scenario
10.2.2.6. U.S. Cancer diagnostics market, 2018 - 2030 (USD BILLION)
10.2.3. Canada
10.2.3.1. Key Country Dynamics
10.2.3.2. Target Disease Prevalence
10.2.3.3. Competitive Scenario
10.2.3.4. Regulatory Framework
10.2.3.5. Reimbursement Scenario
10.2.3.6. Canada Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.3. Europe
10.3.1. Europe Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.3.2. Germany
10.3.2.1. Key Country Dynamics
10.3.2.2. Target Disease Prevalence
10.3.2.3. Competitive Scenario
10.3.2.4. Regulatory Framework
10.3.2.5. Reimbursement Scenario
10.3.2.6. Germany Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.3.3. UK
10.3.3.1. Key Country Dynamics
10.3.3.2. Target Disease Prevalence
10.3.3.3. Competitive Scenario
10.3.3.4. Regulatory Framework
10.3.3.5. Reimbursement Scenario
10.3.3.6. UK Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.3.4. France
10.3.4.1. Key Country Dynamics
10.3.4.2. Target Disease Prevalence
10.3.4.3. Competitive Scenario
10.3.4.4. Regulatory Framework
10.3.4.5. Reimbursement Scenario
10.3.4.6. France Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.3.5. Italy
10.3.5.1. Key Country Dynamics
10.3.5.2. Target Disease Prevalence
10.3.5.3. Competitive Scenario
10.3.5.4. Regulatory Framework
10.3.5.5. Reimbursement Scenario
10.3.5.6. Italy Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.3.6. Spain
10.3.6.1. Key Country Dynamics
10.3.6.2. Target Disease Prevalence
10.3.6.3. Competitive Scenario
10.3.6.4. Regulatory Framework
10.3.6.5. Reimbursement Scenario
10.3.6.6. Spain Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.3.7. Denmark
10.3.7.1. Key Country Dynamics
10.3.7.2. Target Disease Prevalence
10.3.7.3. Competitive Scenario
10.3.7.4. Regulatory Framework
10.3.7.5. Reimbursement Scenario
10.3.7.6. Denmark Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.3.8. Sweden
10.3.8.1. Key Country Dynamics
10.3.8.2. Target Disease Prevalence
10.3.8.3. Competitive Scenario
10.3.8.4. Regulatory Framework
10.3.8.5. Reimbursement Scenario
10.3.8.6. Sweden Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.3.9. Norway
10.3.9.1. Key Country Dynamics
10.3.9.2. Target Disease Prevalence
10.3.9.3. Competitive Scenario
10.3.9.4. Regulatory Framework
10.3.9.5. Reimbursement Scenario
10.3.9.6. Norway Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.4. Asia Pacific
10.4.1. Asia Pacific Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.4.2. Japan
10.4.2.1. Key Country Dynamics
10.4.2.2. Target Disease Prevalence
10.4.2.3. Competitive Scenario
10.4.2.4. Regulatory Framework
10.4.2.5. Reimbursement Scenario
10.4.2.6. Japan Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.4.3. China
10.4.3.1. Key Country Dynamics
10.4.3.2. Target Disease Prevalence
10.4.3.3. Competitive Scenario
10.4.3.4. Regulatory Framework
10.4.3.5. Reimbursement Scenario
10.4.3.6. China Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.4.4. India
10.4.4.1. Key Country Dynamics
10.4.4.2. Target Disease Prevalence
10.4.4.3. Competitive Scenario
10.4.4.4. Regulatory Framework
10.4.4.5. Reimbursement Scenario
10.4.4.6. India Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.4.5. South Korea
10.4.5.1. Key Country Dynamics
10.4.5.2. Target Disease Prevalence
10.4.5.3. Competitive Scenario
10.4.5.4. Regulatory Framework
10.4.5.5. Reimbursement Scenario
10.4.5.6. South Korea Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.4.6. Australia
10.4.6.1. Key Country Dynamics
10.4.6.2. Target Disease Prevalence
10.4.6.3. Competitive Scenario
10.4.6.4. Regulatory Framework
10.4.6.5. Reimbursement Scenario
10.4.6.6. Australia Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.4.7. Thailand
10.4.7.1. Key Country Dynamics
10.4.7.2. Target Disease Prevalence
10.4.7.3. Competitive Scenario
10.4.7.4. Regulatory Framework
10.4.7.5. Reimbursement Scenario
10.4.7.6. Thailand Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.5. Latin America
10.5.1. Latin America Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.5.2. Brazil
10.5.2.1. Key Country Dynamics
10.5.2.2. Target Disease Prevalence
10.5.2.3. Competitive Scenario
10.5.2.4. Regulatory Framework
10.5.2.5. Reimbursement Scenario
10.5.2.6. Brazil Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.5.3. Mexico
10.5.3.1. Key Country Dynamics
10.5.3.2. Target Disease Prevalence
10.5.3.3. Competitive Scenario
10.5.3.4. Regulatory Framework
10.5.3.5. Reimbursement Scenario
10.5.3.6. Mexico Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.5.4. Argentina
10.5.4.1. Key Country Dynamics
10.5.4.2. Target Disease Prevalence
10.5.4.3. Competitive Scenario
10.5.4.4. Regulatory Framework
10.5.4.5. Reimbursement Scenario
10.5.4.6. Argentina Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.6. MEA
10.6.1. MEA Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.6.2. South Africa
10.6.2.1. Key Country Dynamics
10.6.2.2. Target Disease Prevalence
10.6.2.3. Competitive Scenario
10.6.2.4. Regulatory Framework
10.6.2.5. Reimbursement Scenario
10.6.2.6. South Africa Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.6.3. Saudi Arabia
10.6.3.1. Key Country Dynamics
10.6.3.2. Target Disease Prevalence
10.6.3.3. Competitive Scenario
10.6.3.4. Regulatory Framework
10.6.3.5. Reimbursement Scenario
10.6.3.6. Saudi Arabia Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.6.4. UAE
10.6.4.1. Key Country Dynamics
10.6.4.2. Target Disease Prevalence
10.6.4.3. Competitive Scenario
10.6.4.4. Regulatory Framework
10.6.4.5. Reimbursement Scenario
10.6.4.6. UAE Cancer diagnostics market, 2018 - 2030 (USD Billion)
10.6.5. Kuwait
10.6.5.1. Key Country Dynamics
10.6.5.2. Target Disease Prevalence
10.6.5.3. Competitive Scenario
10.6.5.4. Regulatory Framework
10.6.5.5. Reimbursement Scenario
10.6.5.6. Kuwait Cancer diagnostics market, 2018 - 2030 (USD Billion)
Chapter 11. Competitive Landscape
11.1. Participant’s overview
11.2. Financial performance
11.3. Participant categorization
11.3.1. Market Leaders
11.3.2. Cancer Diagnostics Market Share Analysis, 2023
11.3.3. Company Profiles
11.3.3.1. ABBOTT
11.3.3.1.1. Company Overview
11.3.3.1.2. Financial Performance
11.3.3.1.3. Product Benchmarking
11.3.3.1.4. Strategic Initiatives
11.3.3.2. GE HEALTHCARE
11.3.3.2.1. Company Overview
11.3.3.2.2. Financial Performance
11.3.3.2.3. Product Benchmarking
11.3.3.2.4. Strategic Initiatives
11.3.3.3. F. HOFFMANN-LA ROCHE LTD.
11.3.3.3.1. Company Overview
11.3.3.3.2. Financial Performance
11.3.3.3.3. Product Benchmarking
11.3.3.3.4. Strategic Initiatives
11.3.3.4. QIAGEN
11.3.3.4.1. Company Overview
11.3.3.4.2. Financial Performance
11.3.3.4.3. Product Benchmarking
11.3.3.4.4. Strategic Initiatives
11.3.3.5. BD
11.3.3.5.1. Company Overview
11.3.3.5.2. Financial Performance
11.3.3.5.3. Product Benchmarking
11.3.3.5.4. Strategic Initiatives
11.3.3.6. SIEMENS HEALTHCARE GMBH
11.3.3.6.1. Company Overview
11.3.3.6.2. Financial Performance
11.3.3.6.3. Product Benchmarking
11.3.3.6.4. Strategic Initiatives
11.3.3.7. THERMO FISHER SCIENTIFIC, INC.
11.3.3.7.1. Company Overview
11.3.3.7.2. Financial Performance
11.3.3.7.3. Product Benchmarking
11.3.3.7.4. Strategic Initiatives
11.3.3.8. HOLOGIC, INC.
11.3.3.8.1. Company Overview
11.3.3.8.2. Financial Performance
11.3.3.8.3. Product Benchmarking
11.3.3.8.4. Strategic Initiatives
11.3.3.9. KONINKLIJKE PHILIPS N.V. (PHILIPS)
11.3.3.9.1. Company Overview
11.3.3.9.2. Financial Performance
11.3.3.9.3. Product Benchmarking
11.3.3.9.4. Strategic Initiatives
11.3.3.10. ILLUMINA, INC.
11.3.3.10.1. Company Overview
11.3.3.10.2. Financial Performance
11.3.3.10.3. Product Benchmarking
11.3.3.10.4. Strategic Initiatives
11.3.4. Strategy Mapping
11.3.4.1. Expansion
11.3.4.2. Acquisition
11.3.4.3. Collaborations
11.3.4.4. Disease Type/Drug Class Launch
11.3.4.5. Partnerships
11.3.4.6. Others
List of Tables
Table 1 List of abbreviations
Table 2 Global cancer diagnostics market, by region, 2018 - 2030 (USD Billion)
Table 3 Global cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 4 Global cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 5 Global cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 6 Global cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 7 Global cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 8 North America cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 9 North America cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 10 North America cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 11 North America cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 12 North America cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 13 North America cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 14 U.S. cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 15 U.S. cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 16 U.S. cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 17 U.S. cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 18 U.S. cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 19 Canada cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 20 Canada cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 21 Canada cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 22 Canada cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 23 Canada cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 24 Europe cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 25 Europe cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 26 Europe cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 27 Europe cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 28 Europe cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 29 Europe cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 30 UK cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 31 UK cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 32 UK cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 33 UK cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 34 UK cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 35 Germany cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 36 Germany cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 37 Germany cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 38 Germany cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 39 Germany cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 40 France cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 41 France cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 42 France cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 43 France cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 44 France cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 45 Italy cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 46 Italy cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 47 Italy cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 48 Italy cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 49 Italy cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 50 Spain cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 51 Spain cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 52 Spain cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 53 Spain cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 54 Spain cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 55 Denmark cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 56 Denmark cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 57 Denmark cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 58 Denmark cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 59 Denmark cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 60 Sweden cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 61 Sweden cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 62 Sweden cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 63 Sweden cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 64 Sweden cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 65 Norway cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 66 Norway cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 67 Norway cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 68 Norway cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 69 Norway cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 70 Asia Pacific cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 71 Asia Pacific cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 72 Asia Pacific cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 73 Asia Pacific cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 74 Asia Pacific cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 75 Asia Pacific cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 76 Japan cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 77 Japan cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 78 Japan cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 79 Japan cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 80 Japan cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 81 China cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 82 China cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 83 China cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 84 China cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 85 China cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 86 India cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 87 India cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 88 India cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 89 India cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 90 India cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 91 South Korea cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 92 South Korea cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 93 South Korea cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 94 South Korea cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 95 South Korea cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 96 Thailand cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 97 Thailand cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 98 Thailand cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 99 Thailand cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 100 Thailand cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 101 Australia cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 102 Australia cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 103 Australia cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 104 Australia cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 105 Australia cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 106 Latin America cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 107 Latin America cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 108 Latin America cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 109 Latin America cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 110 Latin America cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 111 Latin America cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 112 Brazil cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 113 Brazil cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 114 Brazil cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 115 Brazil cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 116 Brazil cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 117 Mexico cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 118 Mexico cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 119 Mexico cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 120 Mexico cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 121 Mexico cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 122 Argentina cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 123 Argentina cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 124 Argentina cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 125 Argentina cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 126 Argentina cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 127 Middle East & Africa cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 128 Middle East & Africa cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 129 Middle East & Africa cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 130 Middle East & Africa cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 131 Middle East & Africa cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 132 Middle East & Africa cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 133 South Africa cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 134 South Africa cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 135 South Africa cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 136 South Africa cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 137 South Africa cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 138 Saudi Arabia cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 139 Saudi Arabia cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 140 Saudi Arabia cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 141 Saudi Arabia cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 142 Saudi Arabia cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 143 UAE cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 144 UAE cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 145 UAE cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 146 UAE cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 147 UAE cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 148 Kuwait cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 149 Kuwait cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 150 Kuwait cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 151 Kuwait cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 152 Kuwait cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
List of Figures
Fig. 1 Cancer diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Product and type segment snapshot
Fig. 11 Application segment snapshot
Fig. 12 End-use and test type segment snapshot
Fig. 13 Competitive landscape snapshot
Fig. 14 Cancer diagnostics market value, 2023 (USD Billion)
Fig. 15 Market dynamics
Fig. 16 Incidence of most common cancers globally, 2020
Fig. 17 Porter’s five forces analysis
Fig. 18 PESTLE analysis
Fig. 19 Cancer diagnostics market: Product outlook and key takeaways
Fig. 20 Cancer diagnostics market: Product movement analysis
Fig. 21 Instruments market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 22 Pathology-based instruments market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 23 Slide staining systems market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 24 Tissue processing systems market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 25 Cell processors market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 26 PCR instruments market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 27 NGS instruments market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 28 Microarrays market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 29 Other pathology-based instruments market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 30 Imaging instruments market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 32 Consumables market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 33 Antibodies market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 34 Kits & reagents market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 35 Probes market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 36 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 37 Services market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 38 Cancer diagnostics market: Type outlook and key takeaways
Fig. 39 Cancer diagnostics market: Type movement analysis
Fig. 40 IVD market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 41 Diagnosis market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 42 Early detection market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 43 Therapy selection market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 44 Monitoring market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 45 Polymerase Chain Reaction (PCR) market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 46 In Situ Hybridization (ISH) market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 47 Immunohistochemistry (IHC) market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 48 Next-generation Sequencing (NGS) market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 49 Microarrays market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 50 Flow cytometry market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 51 Immunoassays market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 52 Other IVD testing technologies market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 53 LDT market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 54 Imaging market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 55 Magnetic Resonance Imaging (MRI) market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 56 Computed Tomography (CT) market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 57 Positron Emission Tomography (PET) market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 58 Mammography market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 59 Ultrasound market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 60 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 61 Cancer diagnostics market: Application outlook and key takeaways
Fig. 62 Cancer diagnostics market: Application movement analysis
Fig. 63 Breast cancer market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 64 Colorectal cancer market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 65 Cervical cancer market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 66 Lung cancer market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 67 Prostate cancer market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 68 Skin cancer market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 69 Blood cancer market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 70 Kidney cancer market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 71 Liver cancer market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 72 Pancreatic cancer market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 73 Ovarian cancer market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 74 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 75 Cancer diagnostics market: End-use outlook and key takeaways
Fig. 76 Cancer diagnostics market: End-use movement analysis
Fig. 77 Hospitals market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 78 Laboratories market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 79 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 80 Cancer diagnostics market: Test type outlook and key takeaways
Fig. 81 Cancer diagnostics market: Test type movement analysis
Fig. 82 Biopsy market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 83 Fine-needle aspiration market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 84 Core biopsy market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 85 Surgical biopsy market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 86 Skin biopsy/punch biopsy market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 87 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 88 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 89 Cancer Diagnostics Market revenue, by region, 2023 & 2030 (USD Billion)
Fig. 90 Regional marketplace: Key takeaways
Fig. 91 Regional marketplace: Key takeaways
Fig. 92 North America cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 93 Key country dynamics
Fig. 94 U.S. cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 95 Cancer incidence, 2018-2030
Fig. 96 Ways to obtain coverage
Fig. 97 Key country dynamics
Fig. 98 Canada cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 99 Cancer incidence, 2018-2030
Fig. 100 Europe cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 101 Key country dynamics
Fig. 102 UK cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 103 Cancer incidence, 2018-2030
Fig. 104 Key country dynamics
Fig. 105 Germany cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 106 Cancer incidence, 2018-2030
Fig. 107 Key country dynamics
Fig. 108 France cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 109 Cancer incidence, 2018-2030
Fig. 110 Key country dynamics
Fig. 111 Spain cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 112 Cancer incidence, 2018-2030
Fig. 113 Key country dynamics
Fig. 114 Italy cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 115 Cancer incidence, 2018-2030
Fig. 116 Key country dynamics
Fig. 117 Denmark cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 118 Target disease prevalence
Fig. 119 Key country dynamics
Fig. 120 Sweden cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 121 Five most common cancers in Sweden
Fig. 122 Key country dynamics
Fig. 123 Norway cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 124 Number of new cancer cases in 2020, both sexes, all ages
Fig. 125 Rest of Europe cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 126 Asia Pacific cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 127 Key country dynamics
Fig. 128 Japan cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 129 Cancer incidence, 2018 to 2030
Fig. 130 Key country dynamics
Fig. 131 China cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 132 Cancer incidence, 2018 to 2030
Fig. 133 China regulatory details
Fig. 134 Key country dynamics
Fig. 135 India cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 136 Cancer incidence, 2018 to 2030
Fig. 137 Key country dynamics
Fig. 138 Australia cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 139 Cancer incidence, 2018 to 2030
Fig. 140 Key country dynamics
Fig. 141 Thailand cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 142 Cancer incidence, 2020 to 2030
Fig. 143 Key country dynamics
Fig. 144 South Korea cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 145 Cancer incidence 2018 to 2030
Fig. 146 South Korean regulations in four hierarchical orders
Fig. 147 South Korea reimbursement scenario
Fig. 148 Rest of Asia Pacific cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 149 Latin America cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 150 Key country dynamics
Fig. 151 Brazil cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 152 Estimated number of new cancer cases in Brazil
Fig. 153 Key country dynamics
Fig. 154 Mexico cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 155 Estimated number of new cancer cases in Mexico
Fig. 156 Key country dynamics
Fig. 157 Argentina cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 158 Estimated number of new cancer cases in Argentina
Fig. 159 Rest of Latin America cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 160 MEA cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 161 Key country dynamics
Fig. 162 South Africa cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 163 Cancer prevalence-2018-2030
Fig. 164 Key country dynamics
Fig. 165 Saudi Arabia cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 166 Cancer prevalence-2018-2030
Fig. 167 Key country dynamics
Fig. 168 UAE cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 169 Cancer prevalence 2018-2030
Fig. 170 Key country dynamics
Fig. 171 Kuwait cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 172 Target disease prevalence
Fig. 173 Key payers in Kuwait
Fig. 174 Rest of MEA cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 175 Key company categorization
Fig. 176 Company market share analysis, 2023
Fig. 177 Strategic framework

Samples

Loading
LOADING...

Companies Profiled

  • ABBOTT
  • GE HEALTHCARE
  • F. HOFFMANN-LA ROCHE LTD.
  • QIAGEN
  • BD
  • SIEMENS HEALTHCARE GMBH
  • THERMO FISHER SCIENTIFIC, INC.
  • HOLOGIC, INC.
  • KONINKLIJKE PHILIPS N.V. (PHILIPS)
  • ILLUMINA, INC.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages240
PublishedNovember 2023
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 107.45 Billion
Forecasted Market Value ( USD ) by 2030 $ 162.31 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Blood Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Assay Kits And Reagents), By Test (Blood Test, Imaging Test), By End Use (Hospitals & Clinics), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Blood Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Assay Kits And Reagents), By Test (Blood Test, Imaging Test), By End Use (Hospitals & Clinics), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Skin Cancer Diagnostics Market Size, Share & Trends Analysis Report by Cancer Type (Melanoma, Non-Melanoma), Test Type (Dermatoscopy, Skin Biopsy, Lymph Node Biopsy), End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Skin Cancer Diagnostics Market Size, Share & Trends Analysis Report by Cancer Type (Melanoma, Non-Melanoma), Test Type (Dermatoscopy, Skin Biopsy, Lymph Node Biopsy), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 125 Pages
  • Global
From
Liver Cancer Diagnostics Market by Test Type, End User - Global Forecast 2025-2030 - Product Image

Liver Cancer Diagnostics Market by Test Type, End User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Cancer Diagnostics Market by Diagnostic Type, Indication, Components, End-Use - Global Forecast 2025-2030 - Product Image

Cancer Diagnostics Market by Diagnostic Type, Indication, Components, End-Use - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Cancer Diagnostics Market by Diagnostic Type, Application, Regional Outlook - Global Forecast up to 2030 - Product Image

Cancer Diagnostics Market by Diagnostic Type, Application, Regional Outlook - Global Forecast up to 2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.